SCHEMBL4945110

SCHEMBL4945110

CC(=O)Oc1ncccc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
CYP3A4 P08684 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
ALOX12 P18054 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PTPN1 P18031 1/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
LMNA P02545 3/20 0.41
CYP2C9 P11712 2/20 0.41
ABCB11 O95342 1/20 0.41
ESR1 P03372 1/20 0.41
ADRA2A P08913 1/20 0.41
TSHR P16473 1/20 0.41
PDE4A P27815 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRK1 P41145 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1597855 0.86 NOS3 (0.42) KDM4ECYP3A4TDP1ALDH1A1HPGD
SCHEMBL982469 0.85 NPC1 (0.42) KDM4ECYP3A4TDP1NOS3NOS1
SCHEMBL28683997 0.83 PLAU (0.44) KDM4ETDP1HSD17B10NOS3NOS1
SCHEMBL11683709 0.81 HTT (0.41) KDM4ECYP3A4TDP1HPGDLMNA
SCHEMBL10881331 0.81 KDM4E (0.51) KDM4ECYP3A4TDP1ALOX12ALDH1A1
SCHEMBL28806916 0.81 KDM4E (0.44) KDM4ECYP3A4TDP1ALOX12ALDH1A1
SCHEMBL29094492 0.80 MAPT (0.41) KDM4ECYP3A4ALDH1A1HPGDHSD17B10
SCHEMBL4945566 0.79 KDM4E (0.54) KDM4ECYP3A4TDP1ALOX12ALDH1A1
SCHEMBL1291161 0.79 L3MBTL1 (0.43) KDM4ECYP3A4TDP1ALOX12ALDH1A1
SCHEMBL27670976 0.79 KDM4E (0.43) KDM4ECYP3A4TDP1ALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105130886-A Preparation method for 4-fluoro-3-methyl-methyl pyridine-2-carboxylate UNIV HENAN NORMAL 2015-12-09 CN claimed
CN-105061305-A Method for synthesizing 3-methylpyridine-2-carboxylic acid methyl ester in one step UNIV HENAN NORMAL 2015-11-18 CN claimed
CN-103864679-B A kind of preparation method of 3-methyl-2-pyridine carboxylic acid methyl esters HENAN NORMAL UNIVERSITY (CN) 2015-11-18 CN claimed
CN-103864679-A Preparation method for 3-methyl-2-pyridinecarboxylate UNIV HENAN NORMAL 2014-06-18 CN claimed
CN-115181062-A Preparation method of 6-chloro-3-methyl-2-pyridinecarboxylic acid methyl ester 八叶草健康产业研究院(厦门)有限公司 2022-10-14 CN disclosed
CN-109776522-B Substituted heteroaryl compounds, compositions and uses thereof 广东东阳光药业有限公司 2020-12-29 CN disclosed
CN-105130886-A Preparation method for 4-fluoro-3-methyl-methyl pyridine-2-carboxylate UNIV HENAN NORMAL 2015-12-09 CN disclosed
CN-103864679-B A kind of preparation method of 3-methyl-2-pyridine carboxylic acid methyl esters HENAN NORMAL UNIVERSITY (CN) 2015-11-18 CN disclosed
CN-103864679-B A kind of preparation method of 3-methyl-2-pyridine carboxylic acid methyl esters HENAN NORMAL UNIVERSITY (CN) 2015-11-18 CN disclosed
CN-105061305-A Method for synthesizing 3-methylpyridine-2-carboxylic acid methyl ester in one step UNIV HENAN NORMAL 2015-11-18 CN disclosed
CN-103864679-B A kind of preparation method of 3-methyl-2-pyridine carboxylic acid methyl esters HENAN NORMAL UNIVERSITY (CN) 2015-11-18 CN disclosed
CN-103864679-A Preparation method for 3-methyl-2-pyridinecarboxylate UNIV HENAN NORMAL 2014-06-18 CN disclosed
CN-101703507-A Antineoplastic medicament UNIV SHANGHAI JIAOTONG 2010-05-12 CN disclosed
CN-101225070-B Anti-tumor medicine UNIV SHANGHAI JIAOTONG 2010-04-14 CN disclosed
CN-101553480-A Helicobacter pylori degerming agent with gastric acid secretion inhibiting effect ARIGEN PHARMACEUTICALS INC (JP) 2009-10-07 CN disclosed
CN-101400670-A Novel pyridine derivative having anti-helicobacter pylori activity ARIGEN INC (JP) 2009-04-01 CN disclosed
EP-1958946-A1 PYRIDAZINE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed
CN-101225070-A Anti-tumor medicine UNIV SHANGHAI JIAOTONG (CN) 2008-07-23 CN disclosed
CN-101052625-A As P2X7Adamantyl derivatives of receptor antagonists ASTRAZENECA AB (SE) 2007-10-10 CN disclosed
CN-1882589-A Novel heterocyclic compounds as HSP 90-inhibitors CONFORMA THERAPEUTICS CORP (US) 2006-12-20 CN disclosed